EMAIL THIS PAGE TO A FRIEND

Proceedings of the National Academy of Sciences of the United States of America

Deciphering tissue-induced Klebsiella pneumoniae lipid A structure.


PMID 26578797

Abstract

The outcome of an infection depends on host recognition of the pathogen, hence leading to the activation of signaling pathways controlling defense responses. A long-held belief is that the modification of the lipid A moiety of the lipopolysaccharide could help Gram-negative pathogens to evade innate immunity. However, direct evidence that this happens in vivo is lacking. Here we report the lipid A expressed in the tissues of infected mice by the human pathogen Klebsiella pneumoniae. Our findings demonstrate that Klebsiella remodels its lipid A in a tissue-dependent manner. Lipid A species found in the lungs are consistent with a 2-hydroxyacyl-modified lipid A dependent on the PhoPQ-regulated oxygenase LpxO. The in vivo lipid A pattern is lost in minimally passaged bacteria isolated from the tissues. LpxO-dependent modification reduces the activation of inflammatory responses and mediates resistance to antimicrobial peptides. An lpxO mutant is attenuated in vivo thereby highlighting the importance of this lipid A modification in Klebsiella infection biology. Colistin, one of the last options to treat multidrug-resistant Klebsiella infections, triggers the in vivo lipid A pattern. Moreover, colistin-resistant isolates already express the in vivo lipid A pattern. In these isolates, LpxO-dependent lipid A modification mediates resistance to colistin. Deciphering the lipid A expressed in vivo opens the possibility of designing novel therapeutics targeting the enzymes responsible for the in vivo lipid A pattern.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

126209
2,3-Dihydroxybenzoic acid, 99%
C7H6O4
125571
5-Chloro-2-mercaptobenzothiazole, technical grade, ≥90%
C7H4ClNS2
SAB4200176
Anti-JNK antibody, Mouse monoclonal, clone 1C2, purified from hybridoma cell culture
SAB4502398
Anti-JNK1 antibody produced in rabbit, affinity isolated antibody
SAB1406300
Anti-MAPK8 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB4300200
Anti-phospho-MAPK14 (pThr180) antibody produced in rabbit, affinity isolated antibody
SAB4300201
Anti-phospho-MAPK14 (pTyr182) antibody produced in rabbit, affinity isolated antibody
SAB4300194
Anti-phospho-MAPK3 (pThr202) antibody produced in rabbit, affinity isolated antibody
SAB4300195
Anti-phospho-MAPK3 (pTyr204) antibody produced in rabbit, affinity isolated antibody
SAB4504626
Anti-phospho-MNK1 (pThr255) antibody produced in rabbit, affinity isolated antibody
SAB4504714
Anti-phospho-Mnk1 (pThr385) antibody produced in rabbit, affinity isolated antibody
P1491 Anti-phospho-p38 (pThr180/pTyr182) antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
SAB4504095
Anti-phospho-p38 MAPK (pThr179+Tyr181) antibody produced in rabbit, affinity isolated antibody
SAB4504497
Anti-phospho-p38 MAPK (pThr180) antibody produced in rabbit, affinity isolated antibody
SAB4504498
Anti-phospho-p38 MAPK (pTyr182) antibody produced in rabbit, affinity isolated antibody
SAB4504094
Anti-phospho-p38 MAPK (pTyr322) antibody produced in rabbit, affinity isolated antibody
D8284
Bicinchoninic acid disodium salt hydrate, ≥98% (HPLC)
C20H10N2Na2O4 · xH2O
L9504
D-Luciferin, synthetic
C11H8N2O3S2
L6152
D-Luciferin, synthetic, BioXtra, ≥99% (HPLC)
C11H8N2O3S2
WH0005599M2
Monoclonal Anti-MAPK8 antibody produced in mouse, clone 3B3, purified immunoglobulin, buffered aqueous solution
SAB1404249
Monoclonal Anti-MAPK8 antibody produced in mouse, clone 2F11, purified immunoglobulin, buffered aqueous solution